Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II dose-ranging study of SAR441566 plus methotrexate in adults with moderate-to-severe rheumatoid arthritis
CTR20241078Phase 2Completed
- Sponsor
- Sanofi
- Start
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of balinatunfib in rheumatoid arthritis (RA), sponsored by Sanofi. Started Oct 2024; status: completed.
02
Drugs
balinatunfib
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on CTR20241078.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20241078.